user

Immunodulator Effects of Interferon Therapy on Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

被引：0
|
作者：
Kutala, Blaise [1 ,2 ]
Boyer, Nathalie [3 ]
Marchand, Corinne Castelnau [1 ]
Guigui, Nathalie Giuily [4 ]
Sitruk, Veronique [1 ]
Asselah, Tarik [5 ]
Marcellin, Patrick [6 ,7 ]
机构：
[1] Beaujon Hosp, AP HP, Hepatol, Clichy, France
[2] Univ Paris, Inserm 1149, Paris, France
[3] AP HP Beaujon, Hepatogastroenterol, Clichy, France
[4] Beaujon Hosp, Clichy, France
[5] Hop Beaujon, Dept Hepatol, Clichy, France
[6] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France
[7] Univ Paris Diderot, INSERM, Paris, France
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
686
引用
收藏
页码：407A / 408A
页数：2
相关论文
共 50 条
  • [1] Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy
    Shindo, M
    Ken, A
    Okuno, T
    CANCER, 1999, 85 (09) : 1943 - 1950
  • [2] Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Onodera, H
    Ukai, K
    Suzuki, M
    Minami, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 181 (02): : 275 - 283
  • [3] Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy
    Hayashi, K
    Kumada, T
    Nakano, S
    Takeda, I
    Kiriyama, S
    Sone, Y
    Toyoda, H
    Shimizu, H
    Honda, T
    HEPATO-GASTROENTEROLOGY, 2002, 49 (44) : 508 - 512
  • [4] Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Soga, K
    Shibasaki, K
    Aoyagi, Y
    HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1154 - 1158
  • [5] Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hayashi, N
    Kasahara, A
    ONCOLOGY, 2002, 62 : 87 - 93
  • [6] Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C.
    Kasahara, A
    Hayashi, N
    Sasaki, Y
    Kakumu, S
    Kiyosawa, K
    Okita, K
    HEPATOLOGY, 2000, 32 (04) : 361A - 361A
  • [7] Effects of interferon therapy on inhibition of hepatocellular carcinoma development in patients with chronic hepatitis C
    Shiratori, Y
    Yoshida, H
    Omata, I
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (05) : 213 - 214
  • [8] Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
    Imai, Y
    Kawata, S
    Tamura, S
    Yabuuchi, I
    Noda, S
    Inada, M
    Maeda, Y
    Shirai, Y
    Fukuzaki, T
    Kaji, I
    Ishikawa, H
    Matsuda, Y
    Nishikawa, M
    Seki, K
    Matsuzawa, Y
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) : 94 - 99
  • [9] The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment
    Miyajima, I
    Sata, M
    Kumashiro, R
    Uchimura, Y
    Ide, T
    Suzuki, H
    Tanikawa, K
    ONCOLOGY REPORTS, 1998, 5 (01) : 201 - 204
  • [10] The incidence of human hepatocellular carcinoma in chronic hepatitis C patients treated by interferon
    Ifukube, S
    Kimura, T
    Onogi, T
    Niiyama, G
    Mitani, K
    Tamura, T
    Kinoyama, S
    Ito, T
    Yamada, G
    HEPATOLOGY, 1997, 26 (04) : 1339 - 1339
12345